BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22311043)

  • 1. Association of Toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian population.
    Mandal RK; George GP; Mittal RD
    Mol Biol Rep; 2012 Jul; 39(7):7263-9. PubMed ID: 22311043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-nucleotide polymorphisms in genes encoding toll-like receptor -2, -3, -4, and -9 in a case-control study with bladder cancer susceptibility in a North Indian population.
    Singh V; Srivastava N; Kapoor R; Mittal RD
    Arch Med Res; 2013 Jan; 44(1):54-61. PubMed ID: 23142523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility.
    Pandey S; Mittal B; Srivastava M; Singh S; Srivastava K; Lal P; Mittal RD
    Mol Biol Rep; 2011 Oct; 38(7):4715-21. PubMed ID: 21132533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Toll-Like Receptors 2/3/4/9 Gene Polymorphisms in Cervical Cancer Evolution.
    Zidi S; Sghaier I; Gazouani E; Mezlini A; Yacoubi-Loueslati B
    Pathol Oncol Res; 2016 Apr; 22(2):323-30. PubMed ID: 26548749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of Toll-like receptors in cervical cancer susceptibility among Tunisian women.
    Zidi S; Verdi H; Yilmaz-Yalcin Y; Yazici AC; Gazouani E; Mezlini A; Atac FB; Yacoubi-Loueslati B
    Bull Cancer; 2014 Oct; 101(10):E31-5. PubMed ID: 25373689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Toll-like receptor 3 and Toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among Egyptians.
    Hamdy S; Osman AM; Zakaria ZA; Galal I; Sobhy M; Hashem M; Allam WR; Abdel-Samiee M; Rewisha E; Waked I; Abdelwahab SF
    Arch Virol; 2018 Sep; 163(9):2433-2442. PubMed ID: 29860675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association studies of Toll-like receptor gene polymorphisms with allograft survival in renal transplant recipients of North India.
    Srivastava P; Singh A; Kesarwani P; Jaiswal PK; Singh V; Mittal RD
    Clin Transplant; 2012; 26(4):581-8. PubMed ID: 22251233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of neonatal Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in HBV intrauterine transmission susceptibility.
    Gao Y; Guo J; Zhang F; Guo Z; Zhang LR; Wang T; Wang B; Feng SY; Wang SP
    Epidemiol Infect; 2015 Jul; 143(9):1868-75. PubMed ID: 25388852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to HIV-1 infection is influenced by toll like receptor-2 (-196 to -174) polymorphism in a north Indian population.
    Vidyant S; Chatterjee A; Agarwal V; Dhole TN
    J Gene Med; 2017 Aug; 19(8):. PubMed ID: 28730622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
    Mosaad YM; Metwally SS; Farag RE; Lotfy ZF; AbdelTwab HE
    Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Toll like receptor 2 and 9 gene variants with pulmonary tuberculosis: exploration in a northern Indian population.
    Mittal M; Biswas SK; Singh V; Arela N; Katoch VM; Das R; Yadav VS; Bajaj B; Mohanty KK
    Mol Biol Rep; 2018 Aug; 45(4):469-476. PubMed ID: 29675696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations within Toll-like receptor (TLR) and TLR signaling pathway-related genes and their synergistic effects on the risk of Guillain-Barré syndrome.
    Dutta D; Nagappa M; Sreekumaran Nair BV; Das SK; Wahatule R; Sinha S; Vasanthapuram R; Taly AB; Debnath M
    J Peripher Nerv Syst; 2022 Jun; 27(2):131-143. PubMed ID: 35138004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of toll-like receptor gene polymorphisms and its interaction with HPV infection in determining the susceptibility of cervical cancer in Chinese Han population.
    Jin Y; Qiu S; Shao N; Zheng J
    Mamm Genome; 2017 Jun; 28(5-6):213-219. PubMed ID: 28497211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptors genes polymorphisms and the occurrence of HCMV infection among pregnant women.
    Wujcicka W; Paradowska E; Studzińska M; Wilczyński J; Nowakowska D
    Virol J; 2017 Mar; 14(1):64. PubMed ID: 28340580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Relationship of the TLR9 and TLR2 Genetic Polymorphisms with Cervical Cancer Risk: a Meta-Analysis of Case-Control Studies.
    Yang S; Liu L; Xu D; Li X
    Pathol Oncol Res; 2020 Jan; 26(1):307-315. PubMed ID: 30215163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The investigation of toll-like receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patients.
    Etem EO; Elyas H; Ozgocmen S; Yıldırım A; Godekmerdan A
    Rheumatol Int; 2011 Oct; 31(10):1369-74. PubMed ID: 20422193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-nucleotide polymorphisms in genes encoding toll-like receptor -2, -3, -4, and -9 in case-control study with breast cancer.
    Etokebe GE; Knezević J; Petricević B; Pavelić J; Vrbanec D; Dembić Z
    Genet Test Mol Biomarkers; 2009 Dec; 13(6):729-34. PubMed ID: 19810822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort.
    Hong J; Leung E; Fraser AG; Merriman TR; Vishnu P; Krissansen GW
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1760-6. PubMed ID: 17914947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants of chemokine CCL2 and chemokine receptor CCR2 genes and risk of prostate cancer.
    Mandal RK; Agrawal T; Mittal RD
    Tumour Biol; 2015 Jan; 36(1):375-81. PubMed ID: 25266801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Polymorphisms of
    Oliveira-Toré CF; Moraes AG; Martinez GF; Neves JSF; Macedo LC; Rocha-Loures MA; Quirino MG; Alves HV; Sell AM; Visentainer JEL
    J Immunol Res; 2019; 2019():1492092. PubMed ID: 31781672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.